DBX4:F:F-Xtrackers - MSCI EM Europe Middle East & Africa Swap UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 32.97

Change

+0.24 (+0.73)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

+1.68 (+0.33%)

USD 101.74B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.42 (+0.85%)

USD 101.37B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.94 (+1.72%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

+1.28 (+1.41%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+2.10 (+0.94%)

USD 45.80B
0ZC:F Zscaler Inc

+7.96 (+4.26%)

USD 37.92B
BSND:F Danone SA

N/A

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

+0.40 (+0.34%)

USD 24.77B

ETFs Containing DBX4:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.72% 67% D+ 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.72% 67% D+ 64% D
Trailing 12 Months  
Capital Gain 17.92% 89% A- 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.92% 86% B+ 69% C-
Trailing 5 Years  
Capital Gain 58.47% 63% D 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 58.47% 63% D 48% F
Average Annual (5 Year Horizon)  
Capital Gain 7.56% 61% D- 60% D-
Dividend Return 7.56% 58% F 52% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.31% 59% D- 89% A-
Risk Adjusted Return 66.83% 67% D+ 76% C+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike